When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
Scientists at École Polytechnique Fédérale de Lausanne (EPFL) have developed a small laboratory-in-a-box capable of housing and feeding a colony of C. elegans nematodes (roundworms) and testing the…
With the aid of single-cell sequencing technology, researchers at Harvard Medical School have mapped the beginnings of the biological development of both zebrafish and frogs from a single-cell…
Some of the globe’s leading minds in medical research gathered at this year’s World Stem Cell Summit to discuss the recent developments, breakthroughs, and challenges that have arisen…
According to Lars Brouwers, MD, MSc, a physician and PhD-candidate performing research on 3D-printing in the hospital environment, when doctors use traditional x-ray and 2DCT diagnostic tools in…
Dr. Gregory Goodman is the Founder of the Physician Entrepreneur Summit, an online conference with a mission to inspire the next generation of physician entrepreneurs to solve healthcare’s…
